LXRX Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc operates as a biopharmaceutical company engaged in discovery and development of breakthrough treatments for human disease. The company mainly designs and develops drugs for therapeutic areas.

$3.19  -0.06 (-1.85%)
As of 01/21/2022 14:15:30 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  02/23/2001
Outstanding shares:  148,895,707
Average volume:  716,338
Market cap:   $492,844,790
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BWFZX59
Valuation   (See tab for details)
PE ratio:   -7.15
PB ratio:   3.54
PS ratio:   0.00
Return on equity:   -49.52%
Net income %:   -14,004.55%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy